For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Tocagen Inc.

USPTO Granted Patents = 12

% Expired Patents = 41.7

CIPO Patents = 2

EPO Patents = 10

Forward Citations = 22

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Douglas J Jolly (12 out of 53 patents)

Harry E Gruber (10 out of 47 patents)

Omar D Perez (6 out of 6 patents)

4. Christopher R Logg (5 out of 14 patents)

5. Kay Olmstead (3 out of 19 patents)

6. Amy Lin (2 out of 16 patents)

7. Derek G Ostertag (2 out of 4 patents)

8. Joan M Robbins (2 out of 4 patents)

9. Tiffany Huang (2 out of 2 patents)

10. Ryan Burnett (1 out of 3 patents)

11. Carlos E Ibanez (1 out of 8 patents)

12. Noriyuki Kasahara (21 patents)

13. Amy H Lin (0 patent)

12 patents: Sort by Forward Citations

1. 10449194 - Formulations of 5-fluorocytosine and uses thereof (2019-10-22),

2. 10407666 - Recombinant vectors (2019-09-10),

3. 10316333 - Producer cells for replication competent retroviral vectors (2019-06-11),

4. 10035983 - Gene therapy vectors and cytosine deaminases (2018-07-31),

5. 9889133 - Formulations of 5-fluorocytosine and uses thereof (2018-02-13),

6. 9732326 - Recombinant vectors (2017-08-15),

7. 9669049 - Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders (2017-06-06),

8. 9663834 - Retrovirus detection (2017-05-30),

9. 9642921 - Cancer combination therapy and recombinant vectors (2017-05-09),

10. 9320738 - Formulations of 5-fluorocytosine and uses thereof (2016-04-26),

11. 8829173 - Recombinant vectors (2014-09-09),

12. 8722867 - Gene therapy vectors and cytosine deaminases (2014-05-13),

Tocagen Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in gene therapy and immuno-oncology, aiming to harness the body's immune system to target and eliminate cancer cells. Tocagen's proprietary platform is designed to deliver therapeutic genes directly to tumors, enhancing the effectiveness of existing treatments. Through its research initiatives, Tocagen seeks to improve patient outcomes and advance the field of cancer therapeutics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#448 in San Diego, CA

#6,060 in California

#25,540 in US

#48,129 in the World

San Diego, CA, United States of America

Tocagen Inc.

Forward Citations = 22

11 inventors:

Douglas J Jolly (12 out of 53 patents)

Harry E Gruber (10 out of 47 patents)

Omar D Perez (6 out of 6 patents)

4. Christopher R Logg (5 out of 14 patents)

5. Kay Olmstead (3 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…